MedPath
NMPA Approval

Urapidil Hydrochloride Injection

国药准字HJ20160363

May 17, 2021

H20160363

Drug Information

盐酸乌拉地尔注射液

亚宁定

注射剂

5ml:25mg

化学药品

May 17, 2021

May 16, 2026

Company Information

Applicant Company

Takeda GmbH

Byk-Gulden-Straβe2,78467 Konstanz,Germany

Manufacturing Company

St.Peter-Str.25 AT-4020 Linz Austria

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

盐酸乌拉地尔注射液 - NMPA 批准文号 | MedPath